昱展新藥成立於2016年，以505(b)2產品為開發目標，透過自行研發之長效注射針劑平台(In-Relar)，開發治療鴉片類成癮症、難治型憂鬱症及帕金森氏症之長效藥物。
Address
台中市大雅區科雅路32號5樓
Taichung
428
Alerts
Be the first to know and let us send you an email when 昱展新藥 Alar Pharmaceuticals Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to 昱展新藥 Alar Pharmaceuticals Inc.:
Share
